News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Confused about whether cardio or weights is better for losing fat? Discover what the latest research says about burning fat, ...
Comedian Kapil Sharma's weight loss transformation has awed his fans and followers, as he followed the 21-21-21 rule ...
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Keeping Up With the Kardashians' star Khloé Kardashian has been open about her health journey over the years. Here's ...
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...